Pitavastatin intermediate PC4 is a critical synthetic precursor in the pharmaceutical manufacturing of pitavastatin calcium, a potent HMG-CoA reductase inhibitor. The core process involves stereoselective coupling and precise functional group manipulation to ensure high optical purity. While specific CAS numbers for proprietary intermediates vary by manufacturer, this compound typically adheres to the molecular formula C24H26F2N2O5.
Storage requires sealed containers at 2-8°C under inert atmosphere to prevent hydrolysis. Personnel must utilize appropriate PPE including nitrile gloves and safety goggles due to potential irritant properties. Handling should strictly follow GMP guidelines to avoid cross-contamination during clinical trial material preparation.